đź“Š Evidence-Based Reference
sentrant introducer sheath with hydrophilic coating
Medtronic Vascular
Summary: The Sentrant Introducer Sheath with hydrophilic coating is used to facilitate endovascular procedures. Key evidence highlights potential polymer embolization risks.
FDA Clearance Information
Pathway 510K
Number K123990 ↗
Decision Date April 26, 2013
Product Code DYB
Device Class Class 2
Evidence 419 studies
The Sentrant Introducer Sheath was cleared via the FDA 510(k) pathway on April 26, 2013. It is manufactured by Medtronic Vascular and classified as a Class 2 device.
What It Is
The Sentrant Introducer Sheath is a medical device with a hydrophilic coating designed to improve deliverability and minimize vessel trauma during endovascular procedures. It is intended for use in facilitating the introduction of catheters and other devices into the vascular system.
Clinical Applications
Commonly used in endovascular procedures, the Sentrant Introducer Sheath aids in the introduction of devices for interventions such as embolization and aneurysm repair, particularly in complex vascular anatomies.
Evidence Summary
The available literature includes two studies published between 2022 and 2023. These studies explore the mechanical properties and potential complications associated with the hydrophilic coating of the sheath.
Reported Outcomes
Published studies report that the hydrophilic polymer coating can potentially embolize, leading to adverse outcomes such as ischemia and infarction. The studies highlight the need for careful consideration of coating integrity during use.
Safety Profile
Reported complications include the potential for hydrophilic polymer embolization, which may result in serious adverse events such as ischemia, infarction, and even death. These findings underscore the importance of monitoring for coating integrity.
Evidence Limitations
The evidence is limited by the small number of studies and the lack of large-scale clinical trials. Further research is needed to quantify the clinical impact of polymer embolization and to explore mitigation strategies.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source → PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source → PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source → PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source → PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source → PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source → PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source → PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source → PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source → PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for the Sentrant Introducer Sheath?
The Sentrant Introducer Sheath is indicated for use in facilitating the introduction of devices into the vascular system during endovascular procedures.
What outcomes have been reported in clinical studies?
Studies have reported potential polymer embolization from the hydrophilic coating, which can lead to adverse outcomes such as ischemia and infarction.
What complications have been reported?
Reported complications include polymer embolization, which may result in serious adverse events like ischemia, infarction, and death.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.